These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22505536)

  • 21. Correlation between serum HER-2 oncoprotein and patients with breast cancer.
    Yuan P; Xu BH; Chu DT
    Chin Med Sci J; 2004 Sep; 19(3):212-5. PubMed ID: 15506651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hidden HER-2/neu-positive breast cancer: how to maximize detection.
    Carney WP
    IDrugs; 2009 Apr; 12(4):238-42. PubMed ID: 19350468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of C-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases.
    Molina R; Jo J; Filella X; Bruix J; Castells A; Hague M; Ballesta AM
    Tumour Biol; 1997; 18(3):188-96. PubMed ID: 9143415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the HER-2/neu oncogene in gynecologic cancers.
    Cirisano FD; Karlan BY
    J Soc Gynecol Investig; 1996; 3(3):99-105. PubMed ID: 8796816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An investigation of extracellular HER-2/NEU domain level in blood serum from breast cancer patients].
    Korytova LI; Masliukova EA; Ovchinnikov IV; Filipenko MO; Korytov OV; Kudaĭbergenova AG
    Vopr Onkol; 2010; 56(1):62-5. PubMed ID: 20361618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
    Samy N; Ragab HM; El Maksoud NA; Shaalan M
    Cancer Biomark; 2010; 6(2):63-72. PubMed ID: 20571232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer.
    Ali SM; Leitzel K; Chinchilli VM; Engle L; Demers L; Harvey HA; Carney W; Allard JW; Lipton A
    Clin Chem; 2002 Aug; 48(8):1314-20. PubMed ID: 12142389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.
    Müller V; Witzel I; Lück HJ; Köhler G; von Minckwitz G; Möbus V; Sattler D; Wilczak W; Löning T; Jänicke F; Pantel K; Thomssen C
    Breast Cancer Res Treat; 2004 Jul; 86(1):9-18. PubMed ID: 15218357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer.
    Kuerer HM; Thompson PA; Krishnamurthy S; Fritsche HA; Marcy SM; Babiera GV; Singletary SE; Cristofanilli M; Sneige N; Hunt KK
    Clin Cancer Res; 2003 Feb; 9(2):601-5. PubMed ID: 12576424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer.
    Schippinger W; Regitnig P; Bauernhofer T; Ploner F; Hofmann G; Krippl P; Wehrschütz M; Lax S; Carney W; Neumann R; Wernecke KD; Samonigg H
    Oncol Rep; 2004 Jun; 11(6):1331-6. PubMed ID: 15138574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancer.
    Lüftner D; Mazurek S; Henschke P; Mesterharm J; Schildhauer S; Geppert R; Wernecke KD; Possinger K
    Anticancer Res; 2003; 23(2A):991-7. PubMed ID: 12820337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy.
    Lipton A; Leitzel K; Ali SM; Demers L; Harvey HA; Chaudri-Ross HA; Evans D; Lang R; Hackl W; Hamer P; Carney W
    Cancer; 2005 Jul; 104(2):257-63. PubMed ID: 15952182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum her-2/neu and survivin levels and their relationship to histological parameters in early-stage breast cancer.
    Goksel G; Taneli F; Uslu R; Ulman C; Dinc G; Coskun T; Kandiloglu AR
    J Int Med Res; 2007; 35(2):165-72. PubMed ID: 17542404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of shed Her2/neu protein in men with prostate cancer correlate with disease progression.
    Osman I; Mikhail M; Shuch B; Clute M; Cheli CD; Ghani F; Thiel RP; Taneja SS
    J Urol; 2005 Dec; 174(6):2174-7. PubMed ID: 16280758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum c-erbB-2 protein is a useful marker for monitoring tumor recurrence of the breast.
    Imoto S; Wada N; Hasebe T; Ochiai A; Kitoh T
    Int J Cancer; 2007 Jan; 120(2):357-61. PubMed ID: 17044019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change of HER-2/neu status in a subset of distant metastases from breast carcinomas.
    Regitnig P; Schippinger W; Lindbauer M; Samonigg H; Lax SF
    J Pathol; 2004 Aug; 203(4):918-26. PubMed ID: 15258994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum HER-2/neu: a new predictive marker.
    Voss A; Neumann R
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):584-5. PubMed ID: 12503824
    [No Abstract]   [Full Text] [Related]  

  • 39. Longitudinal changes in serum HER-2/neu oncoprotein levels in trastuzumab-treated metastatic breast cancer patients.
    Bethune-Volters A; Labroquere M; Guepratte S; Hacene K; Neumann R; Carney W; Pichon MF
    Anticancer Res; 2004; 24(2C):1083-9. PubMed ID: 15154627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic and predictive values of circulating HER-2/neu extracellular domain in patients with metastatic breast cancer.
    Abu-Khalaf MM; Harris L
    Breast Cancer Res Treat; 2009 Apr; 114(3):513-5. PubMed ID: 18677560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.